Search results :

Sitagliptin

More information: STITCH, PubChem and possibly Wikipedia

ATC Code: A10BH01

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11
Hypoglycaemia postmarketing, common x x x x x x x x x x
Nasopharyngitis postmarketing, 2.48% - 5.19% 1.1% - 3.31% x x x x x x x x x x
Upper respiratory tract infection postmarketing, 2.26% - 5.22% 1.38% - 5.11% x x x x x x x x x x
Headache postmarketing — 1.12% - 3.85% 1.38% - 2.84% x x x x x x x x x x x
Dizziness postmarketing, uncommon x x x x
Pancreatitis acute postmarketing x x x x x x x x x
Anaphylactic shock postmarketing x x x x x x x x
Angioedema postmarketing x x x x x x x x x x x
Arthralgia postmarketing x x x x x x x x x
Back pain postmarketing x x x x x x x x x
Infection postmarketing x x x x
Connective tissue disorder postmarketing x x x x
Constipation postmarketing, uncommon x x x x x x x x x x
Diarrhoea postmarketing x x x x x x x x x x x
Rash postmarketing x x x x x x x x x x x
Flatulence postmarketing x x x x x
Gastrointestinal disorder postmarketing x x x x
Hypersensitivity postmarketing x x x x x x x x x x x
Immune system disorder postmarketing x x x
Influenza postmarketing x x x x x
Renal failure acute postmarketing x x x x x x x x x
Mediastinal disorder postmarketing x x x x
Nausea postmarketing x x x x x x x x x x x
Nervous system disorder postmarketing x x x
Osteoarthritis postmarketing x x x x
Pain in extremity postmarketing x x x x x x x x x
Pancreatitis postmarketing x x x x
Skin disorder postmarketing x x x x x x x x x x x
Stevens-Johnson syndrome postmarketing x x x x x x x x x x x
Urinary tract disorder postmarketing x x x
Urticaria postmarketing x x x x x x x x x x x
Vomiting postmarketing x x x x x x x x x x
Dry mouth postmarketing x x x
Oedema peripheral postmarketing x x x x x x x x x x x
Malnutrition postmarketing x x x x
Unspecified disorder of skin and subcutaneous tissue postmarketing x x x
Myalgia postmarketing x x x x x x x x x
Abdominal pain upper postmarketing x x x x
Cutaneous vasculitis postmarketing x x x x x x x x x
Pancreatitis necrotising postmarketing x x x x x x x x x
Blood glucose decreased postmarketing x x x x x
Infestation NOS postmarketing x x x x
Anaphylactic responses postmarketing x x x
Renal impairment postmarketing x x
Somnolence postmarketing x x x x
Abdominal pain x x x x x x x x
Anxiety x
Mental disorder x
Breast disorder x
Bronchitis x
Bundle branch block x
Cellulitis x
Neck pain x
Contusion x
Cough x x
Depression x
Fungal skin infection x
Dysmenorrhoea x
Dyspepsia x x
Eczema x
Reflux esophagitis x
Eye disorder x
Fatigue x
Gastroenteritis x
Cardiac disorder x
Herpes zoster x
Hyperglycaemia x
Hypertension x
Hypoaesthesia x
Orthostatic hypotension x
Lung disorder x
Nervousness x
Pain x
Neuropathy peripheral x
Pharyngitis x
Pneumonia x
Respiratory tract infection x
Sciatica x
Shoulder pain x
Sinus headache x
Sinusitis x
Muscle spasms x
Toothache x
Urinary tract infection x
Angiopathy x
Vertigo x
Weight increased x
Acute bronchitis x
Migraine x
Sinus congestion x
Viral diarrhoea x
Malaise x
Decreased appetite x
Abdominal discomfort x
Retching x
Erectile dysfunction x
Hepatobiliary disease x
Helicobacter gastritis x
Vision blurred x
Nephrolithiasis x
Non-cardiac chest pain x
Face oedema x
Blood glucose increased x
Serum creatinine increased x x x x x x
Ear and labyrinth disorders x
Pharyngolaryngeal pain x
Tooth infection x
Muscle tightness x
Insomnia x
Gastric ulcer helicobacter x
Parosmia x
Hepatic steatosis x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

SITAGLIPTIN

Side effects:19
Source:FDA Structured Product Label

SITAGLIPTIN

Side effects:22
Source:FDA Structured Product Label

SITAGLIPTIN

Side effects:26
Source:FDA Structured Product Label

SITAGLIPTIN

Side effects:26
Source:FDA Structured Product Label

SITAGLIPTIN

Side effects:26
Source:FDA Structured Product Label

SITAGLIPTIN

Side effects:26
Source:FDA Structured Product Label

sitagliptin / sitagliptin

Side effects:38
Source:EMA

sitagliptin / sitagliptin

Side effects:44
Source:EMA

sitagliptin / sitagliptin

Side effects:44
Source:EMA

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label